Sun Pharmaceutical NSE - 0.01 % Industries Ltd has resolved to give Rs 25 crore worth of <span style="color: #ff6600;"><a style="color: #ff6600;" href="https://www.theweek.in/news/health/2020/03/23/the-promise-of-hydroxychloroquine-for-prevention-of-covid-19.html">Hydroxychloroquine (HCQS), Azithromycin</a></span>, other related medications and hand sanitisers to help India's battle against coronavirus pandemic, as indicated by an organization articulation. The national team for COVID-19 comprised by Indian Council of Medical Research has suggested HCQS as prophylaxis of the contamination for high hazard populace.

HCQS is being concentrated by the <span style="color: #ff6600;"><a style="color: #ff6600;" href="https://www.youtube.com/channel/UC07-dOwgza1IguKA86jqxNA">World Health Organization (WHO</a></span>) for use related to Azithromycin to treat COVID-19. "The organization is focused on working intimately with the legislatures and applicable partners to guarantee there is continuous stockpile of drugs," Sun Pharma said in an announcement. The organization is comprising a team to deal with the dispersion of these items in India, it included.

Recognizing the endeavors of the whole clinical and bolster organization in battling COVID-19, <span style="color: #ff6600;"><a style="color: #ff6600;" href="https://en.wikipedia.org/wiki/Sun_Pharmaceutical">Sun Pharma</a></span> said,"To help these cutting edge warriors, the organization has repurposed its fluid assembling office in India to deliver top notch hand sanitisers." These will be made accessible to social insurance experts serving their networks and the country, it included. The residential pharma major additionally said it has initiated telecommute for all colleagues who can work remotely at all its areas.